Report: 2014 - The Impact of Internet Regulation on Early Stage Investment

Report: 2014 - The Impact of Internet Regulation on Early Stage Investment

In 2014, we surveyed 330 investors in eight countries around the world (Australia, France, Germany, India, Italy, Spain, the UK and the US) in order to assess the degree to which the future legal environment might impact their behavior concerning investing in Digital Content Intermediaries (DCIs).

Authors: Matthew C. Le Merle, Evan Engstrom and Tallulah J. Le Merle

Report: Angel Networks: A Better Mousetrap

With the demise of the traditional venture capital fund model and the rise of organized angel networks we are seeing an increasing proportion of early stage companies receiving their first round of external financing from angels, angel networks and most recently online angel lists and posts.

This article, originally published in 2007, outlines why angel networks provide superior advantages for the individual angels as they go about their investment decision making.

Download PDF

Press: The Bay Area's Golden Age

When it comes to money, technology and talent, right now all roads lead to the Bay Area.

That includes Wall Street, Hollywood Boulevard and the streets of the financial districts of Shanghai and Hong Kong.

The Bay Area is enjoying a virtuous cycle of money financing startups that create jobs and companies that, in turn, will be acquired or go public one day, triggering another wave of wealthy investors and innovation.

“Success breeds success,” said Matthew Le Merle, a Marin County investor in several Bay Area startups.

“If you’re young, ambitious and have an entrepreneurial dream, you come to the Bay Area,” said Le Merle, managing partner at Fifth Era. He sees the Bay Area’s rising tech-fueled fortunes entering 2014 as simply the latest magnet to the region, a theme going back to those pulled here by gold fever.

Report: Nimble Partnerships in the Pharma Industry

Report: Nimble Partnerships in the Pharma Industry

In 2011 we conducted qualitative research to gain insight into the ways pharmaceutical companies engage with their clinical research organization (CRO) partners. A “new nimble” approach to CRO relationships based on developing differentiated internal capabilities and building on outside partnerships allows pharmaceutical companies to stay ahead of changing market dynamics and generate value at every point in their organizations.

Report: Standing Up a Cloud-Enabled Marketing Capability

Authors: Matthew Le Merle and Phil Minasian

Marketing’s challenge has always been to develop customer insights, targeted value propositions, and powerful communications in an iterative cycle. The Internet has given marketers a glimpse of how each element of that cycle can be dramatically transformed by new technologies that allow direct customer interactions, the ability to test and modify value propositions on the fly, and the opportunity to present the communication that best fits the customer at any point in the process—while constantly iterating the process as the marketing cycle collapses toward real time.

Download PDF